Some preliminary research suggests it may have hepatoprotective properties, though patients with pre-existing liver disease should discuss use with their hepatologist
On average, tirzepatide produces more weight loss at maximum dose
These research findings suggest that EW may contribute to reducing the risk of secondary infarction or disease exacerbation (Yue et al., 2019)
While occasional drinking may be possible, reducing alcohol often leads to better outcomes
Whether the medication caused it, accelerated a subclinical condition, or simply unmasked something already there is nearly impossible to determine
Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers